Key facts
- It has raised $145.0M; the latest was Later Stage VC in Apr 2025.
- Notable investors include HSG (Hong Kong), Baidu Ventures, 5Y Capital, Source Code Capital, CMB International Capital — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Bota Biosciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Bota Biosciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bota Biosciences
Developer of bioengineering technology designed for bio-manufacturing. The company offers high-flux platform strains and fermentation processes for microbial production of high-performing industrial compounds, thereby meeting the market demand of industrial biotechnology.
- Sector
- Healthcare
- HQ
- Hangzhou, China
- Founded
- 2019
- Employees
- 100
- Website
- bota.bio/
- Ownership
- Privately Held (backing)
Bota Biosciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bota Biosciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bota Biosciences in its N-PORT filings yet. We sweep new filings monthly.